| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |